Stem Cell Reports · 2022 · 41 citations · 35 references
Life SciencesCell BiologyMolecular BiologyCell SignalingSignal TransductionStem Cell BiologyBone Marrow PhysiologyBone Morphogenetic Protein SignalingCartilage BiologyCartilage MetabolismMesenchymal DifferentiationOsteogenesisBmp In ChondrogenesisBmp Signal TransductionBmp Signaling InhibitionBone Marrow-derived Mesenchymal Stromal CellsMesenchymal Stromal Cell Fate Specification
Bone morphogenetic protein (BMP) cascades are upregulated during bone marrow-derived stromal cell (BMSC) chondrogenesis, contributing to hypertrophy and preventing effective BMSC-mediated cartilage repair. Previous work demonstrated that a proprietary BMP inhibitor prevented BMSC hypertrophy, yielding stable cartilage tissue. Because of the significant therapeutic potential of a molecule capable of hypertrophy blockade, we evaluated the capacity of a commercially available BMP type I receptor inhibitor with similar properties, LDN 193189, to prevent BMSC hypertrophy. Using 14-day microtissue chondrogenic induction cultures we found that LDN 193189 permitted BMSC chondrogenesis but did not prevent hypertrophy. LDN 193189 was sufficiently potent to counter mineralization and adipogenesis in response to exogenous BMP-2 in osteogenic induction cultures. LDN 193189 did not modify BMSC behavior in adipogenic induction cultures. Although LDN 193189 is effective in countering BMP signaling in a manner that influences BMSC fate, this blockade is insufficient to prevent hypertrophy.
35
C/EBPα induces adipogenesis through PPARγ: a unified pathway
Evan D. Rosen, Chung-Hsin Hsu, Xinzhong Wang et al. · Genes & Development · 2002 · 1.5K citations · Full text
BMP type I receptor inhibition reduces heterotopic ossification
Paul B. Yu, Donna Y. Deng, Carol Lai et al. · Nature Medicine · 2008 · 628 citations · Full text